Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2774-2784

  Crawford, J ^a   O'Rourke, M ^a   Schiller, J H ^a   Spiridonidis, C H ^a   Yanovich, S ^a   Ozer, H ^a   Langleben, A ^a   Hutchins, L ^a   Koletsky, A ^a   Clamon, G ^a   Burman, S ^a   White, R ^a   Hohneker, J ^a   Spiridonitis, C H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; NAVELBINE;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GRANULOCYTOPENIA; HUMAN; INJECTION SITE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 10144246570     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2774     Document Type: Article

References (29)

1. Souquet PJ, Chauvin F, Boissel JP, et al: Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis. Lancet 342:19-21, 1993
2. Grilli R, Oxman AD, Julian JA: Chemotherapy for advanced non-small cell lung cancer: How much benefit is enough? J Clin Oncol 11:1866-1872, 1993
3. Berthaud P, Le Chevalier T, Ruffié P, et al: Phase I-II study of Navelbine (vinorelbine) plus cisplatin in advanced non-small cell lung cancer. Eur J Cancer 28A: 1863-1865, 1992
4. Depierre A, Lemarie E, Dabouis G, et al: A phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 14:115-119, 1991
5. Yokoyamri A, Furusek, Niitani H, et al: Multi-institutional phase II study of Navelbine (vinorelbine) in non-small cell lung cancer. Proc Am Soc Clin Oncol 11:287, 1992 (abstr)
6. Le Chevalier T, Brisgand D, Douillard J, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
7. O'Rourke M, Crawford J, Schiller J, et al: Survival advantage for patients with stage IV NSCLC treated with single-agent Navelbine in a randomized controlled trial. Proc Am Soc Clin Oncol 12:343, 1993 (abstr)
8. Moinpour CM, Hayden KA, Thompson IM, et al: Quality-of-life assessment in Southwest Oncology Group trials. Oncology 4:7989, 1990
9. Cartei G, Cartei F, Cantone A, et al: Cisplatin-cyclophosphamide- mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small cell lung cancer. J Natl Cancer Inst 85:794-800, 1993
10. Cormier Y, Bergeron D, La Forge J, et al: Benefits of polychemotherapy in advanced non-small cell bronchogenic carcinoma. CA 50:845-849, 1982
11. Ganz PA, Figlin RA, Haskell CM, et al: Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. CA 63:1271-1278, 1989
12. Kris MG, Gralla RJ, Kalman LA, et al: Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 69:387-395, 1985
13. Cellerino R, Tummarello D, Guidi F, et al: A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 9:1453-1461, 1991
14. Evans WK: Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: Report of a Canadian multicenter randomized trial. Semin Oncol 15:42-45, 1988
15. Kaasa S, Lund E, Thorud E, et al: Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. CA 67:2443-2447, 1991
16. Quoix É, Dietemann A, Charbonneau J, et al: La chimioth é rapie comportant du cisplatine est-elle utile dans le cancer bronchique non microcellulaire au stade IV? R é sultats d'une é tude randomis é e. Bull Cancer 78:341-346, 1991
17. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer-Report of a Canadian multicenter randomized trial. J Clin Oncol 6:4:633-641, 1988
18. Williams CJ, Woods R, Levi J, et al: Chemotherapy for nonsmall lung cancer: A randomized trial of cisplatin/vindesine versus no chemotherapy. Semin Oncol 15:58-61, 1988
19. Woods RL, Williams CJ, Levi J, et al: A randomized trial of cisplatin and vindesine versus supportive care only in advanced nonsmall cell lung cancer. Br J Cancer 61:608-611, 1990
20. Rittenberg CR, Gralla RJ, Rehmeyer AT: Assessing and man- aging venous irritation associated with vinorelbine tartrate (Navelbine). Oncol Nurs Forum 22:707-710, 1995
21. Dorr RT, Bool KL: Antidote studies of vinorelbine-induced skin ulceration in the mouse. Cancer Chemother Pharmacol 36:290-292, 1995
22. Fellous A, Ohayon R, Vacassin T, et al: Biochemical effects of Navelbine on tubulin and associated proteins. Semin Oncol 16:914, 1989
23. Weber BL, Vogel C, Jones S, et al: Intravenous vinorelbine and first-line and second-line therapy in advanced breast cancer. J Clin Oncol 13:2722-2730, 1995
24. Smith TJ, Hillner BE, Neighbors DM, et al: Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small cell lung cancer. J Clin Oncol 13:2166-2173, 1995
25. Gralla R, Kardinal C, Clark R, et al: Enhancing the safety, efficacy, and dose intensity of vinorelbine (Navelbine) in combina- tion chemotherapy regimens. Proc Am Soc Clin Oncol 12:336, 1993 (abstr).
26. Drinkard L, Huffman P, Bitran J, et al: A phase I-II trial of Navelbine and ifosfamide with granulocyte colony stimulating factor support in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 13:354, 1994 (abstr)
27. Crawford J, ORourke M, Hohneker J, et al: A phase I/II trial of carboplatin and Navelbine in advanced non-small cell lung cancer. Proc World Conf Lung Cancer 7:9, 1994 (abstr)
28. Langer CJ, Leighton JC, Comis RL, et al: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
29. Johnson DH, Einhorn LH: Paclitaxel plus carboplatin: An effective combination chemotherapy for advanced non-small-cell lung cancer or just another Elvis sighting? J Clin Oncol 13:1840-1842, 1995